Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective, Non-controlled, Safety Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease (PROMISE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01599702
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:56.083341+00:00
Published At
2015-04-29T00:00:00+00:00
Record Updated At
2015-04-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Inflammatory Bowel Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-04-29"
protocolSection.identificationModule.nctId
"NCT01599702"
protocolSection.identificationModule.officialTitle
"A Prospective, Non-controlled, Safety Study of Intravenous Iron Isomaltoside 1000 (Monofer\u00ae) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease (PROMISE)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Inflammatory Bowel Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.